Pectolvan C manufactured by Farmak JSC is a medicinal product registered in accordance with the current Register of Medicinal Products and is authorized for medical use in Ukraine.
However, in December 2017, Farmak JSC recalled six batches of Pectolvan C from the market due to minor deviations in the ‘Description’ parameter. Farmak JSC has uncompromising attitude towards quality, so the company has notified the State Service of Ukraine for Medicines and all distributors in due time, in accordance with the GMP requirements.
Today, Pectolvan C, just like all other Farmak products available on the market, in pharmacies and from distributors, complies with the quality standards and is authorized for medical use in Ukraine.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...